Clinical Trials Browser

Phase 2 × Erythema Multiforme × Capecitabine × Clear all

NCT00671645 2020-10-19

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Phase 2 Terminated

Gastrointestinal

Carcinoma, Erythema Multiforme, Rectal Neoplasms